Etiopathogenesis of cardiomyopathies: a review

I Kirvalidze1, T Jorbenadze, R Khetsuriani

  • 1Tbilisi Scientific Practical Center of Clinical Pathology.

Georgian Medical News
|October 6, 2009
PubMed

Insights

Cardiomyopathy remains a complex heart condition with unclear causes and treatments. Further research is needed to understand factors affecting heart function and develop new therapies.

Area of Science:

  • Cardiology
  • Pathology
  • Virology

Background:

  • Cardiomyopathy etiology, pathogenesis, and classification lack universal consensus.
  • Coxsackie B viruses and smoking are implicated in cardiomyopathy development.
  • Distinguishing congestive and ischemic cardiomyopathy presents diagnostic challenges.

Purpose of the Study:

  • To review the etiopathogenesis of cardiomyopathy.
  • To highlight the need for further investigation into unexplored aspects of cardiomyopathy.
  • To identify factors influencing cardiac contractile function.

Main Methods:

  • Literature review of etiopathogenesis of cardiomyopathy.
  • Analysis of etiological factors including viral infections and environmental influences like smoking.
  • Discussion of diagnostic complexities and current terminology.

Main Results:

  • Etiology and pathogenesis of cardiomyopathy are not fully understood.
  • Smoking significantly impacts cellular oxidative and energetic processes, relevant to cardiomyopathy.
  • Clinical presentation of congestive and ischemic cardiomyopathy can be similar, necessitating careful diagnosis.

Conclusions:

  • Cardiomyopathy is a complex pathology requiring further etiological and pathogenetic investigation.
  • Understanding factors affecting cardiac contractile function is crucial.
  • Development of novel therapeutic agents is essential for effective cardiomyopathy management.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...